John E. Niederhuber was the 13th director of the National Cancer Institute (NCI),[1]
from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime.[clarification needed] A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director,[2] National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.[3]
^"John E. Niederhuber, MD". Johns Hopkins Institute for Clinical and Translational Research. 2011. Archived from the original on 2012-12-10. Retrieved 2012-08-14.
